The targeting of factors necessary for expression of methicillin resistance in staphylococci

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 6, 1998, Pages 581-584

  Labischinski, H ^a   Ehlert, K ^a   Berger Bachi B ^b  

^a BAYER AG   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

BACTERIAL GENE; CROSS RESISTANCE; DNA SEQUENCE; HOSPITAL INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; OPERON; SHORT SURVEY;

BACTERIAL PROTEINS; GENES, BACTERIAL; METHICILLIN RESISTANCE; STAPHYLOCOCCUS;

EID: 0031813346     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.6.581     Document Type: Short Survey

References (27)

1. Noble, W. C., Virani, Z. & Cree, R. G. (1992). Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiology Letters 72, 195-8.
2. Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T. & Tenover, F. C. (1997). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. Journal of Antimicrobial Chemotherapy 40, 135-6.
3. Williams, D., Bergan, T. & Moosdeen, F., Eds (1997). Arrival of vancomycin resistance in Staphylococcus aureus. In Antibiotics Chemotherapy, Vol. 1, no. 2, p. 1 (Newsletter of the International Society of Chemotherapy). Cambridge Medical Publications, Worthing.
4. Berger-Bächi, B. (1983). Insertional inactivation of staphylococcal methicillin resistance by Tn551. Journal of Bacteriology 154, 479-87.
5. Berger-Bächi, B. (1994). Expression of resistance to methicillin. Trends in Microbiology 2, 389-93.
6. Vasilieva, E., Labischinski, H. & Berger-Bächi, B. (1997). Identification and mapping of new chromosomal sites affecting response to β-lactams in Staphylococcus aureus. International Journal of Antimicrobial Agents 8, 13-21.
7. de Lencastre, H. & Tomasz, A. (1994). Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 38, 2590-8.
8. Tomasz, A. (1990). Auxiliary genes assisting in the expression of methicillin resistance in Staphylococcus aureus. In Molecular biology of the staphylococci (Novick, R. A., Ed.), pp. 565-83. VCH, New York.
9. Ornelas-Soares, A., de Lencastre, H., DeJonge, B. L. & Tomasz, A. (1994). Reduced methicillin resistance in a new Staphylococcus aureus transposon mutant that incorporates muramyl dipeptides into the cell wall peptidoglycan. Journal of Biological Chemistry 269, 27246-50.
10. Hürlimann-Dalel, R. L., Ryffel, C., Kayser, F. H. & Berger-Bächi, B. (1992). Survey of the methicillin resistance-associated genes mecA, mecR1-mecl, and femA-femB in clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 36, 2617-21.
11. Kobayashi, N., Wi, H., Kojima, K., Taniguchi, K. S., Urasawa, S., Uehara, N. et al. (1994). Detection of mecA, femA, and femB genes in clinical strains of staphylococci using polymerase chain reaction. Epidemiology and Infection 113, 259-66.
12. Berger-Bächi, B., Barberis-Maino, L., Strässle, A. & Kayser, F. H. (1989). FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization. Molecular and General Genetics 219, 263-9.
13. Johnson, S., Krüger, D. & Labischinski, H. (1995). FemA of Staphylococcus aureus: isolation and immunodetection. FEMS Microbiology Letters 132, 221-8.
14. Labischinski, H. (1992). Consequences of the interaction of β-lactam antibiotics with penicillin binding proteins from sensitive and resistant Staphylococcus aureus strains. Medical Microbiology and Immunology 181, 241-65.
15. Matsuhashi, M., Dietrich, C. P. & Strominger, J. L. (1967). Biosynthesis of the peptidoglycan of bacterial cell walls. III. Journal Biological Chemistry 242, 3191-206.
16. Thorndike, J. & Park, J. T. (1969). A method for demonstrating the stepwise addition of glycine from transfer RNA into the murein precursor of Staphylococcus aureus. Biochemical and Biophysical Research Communications 34, 642-7.
17. Henze, U., Sidow, T., Wecke, J., Labischinski, H. & Berger-Bächi, B. (1993). Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus. Journal of Bacteriology 175, 1612-20.
18. Maidhof, H., Reinicke, B., Blümel, P., Berger-Bächi, B. & Labischinski, H. (1991). femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. Journal of Bacteriology 173, 3507-13.
19. de Jonge, B. L., Sidow, T., Chang, Y. S., Labischinski, H., Berger-Bächi, B., Gage, D. A. et al. (1993). Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus. Journal of Bacteriology 175, 2779-82.
20. Kopp, U., Roos, M., Wecke, J. & Labischinski, H. (1996). Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target? Microbial Drug Resistance 2, 29-41.
21. Stranden, A. M., Ehlert, K., Labischinski, H. & Berger-Bächi, B. (1997). Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. Journal of Bacteriology 179, 9-16.
22. Ehlert, K., Schroder, W. & Labischinski, H. (1997). Specificities of FemA and FemB for different glycine residues: FemB cannot substitute for FemA in staphylococcal peptidoglycan pentaglycine side chain formation. Journal of Bacteriology 179, 7573-6.
23. Albortn, W. E., Hoskins, J., Flokowitsch, J. E. & Skatrud, P. L. (1994). Cloning and characterization of femA and femB genes from Staphylococcus epidermidis and Staphylococcus haemolyticus. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract c59, p. 77. American Society for Microbiology, Washington, DC.
24. Thumm, G. & Götz, F. (1997). Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus. Molecular Microbiology 23, 1251-65.
25. Sugai, M., Fujiwara, T., Ohta, K., Komatsuzawa, H., Ohara, M. & Suginaka, H. (1997). epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus. Journal of Bacteriology 179, 4311-8.
26. Levy, S. B. (1997). Antibiotic resistance: an ecological imbalance. Ciba Foundation Symposium 207, 1-9.
27. Schleifer, K. H. & Kandler, O. (1972). Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriological Reviews 36, 407-77.